FTD-Bayern
Care situation of people with frontotemporal dementia and further development of needs-based care structures in Bavaria
Project overview
Duration: 2022-2024 …
Frank Jessen is a New Member of the World Dementia Council
The DZNE scientist investigates the early detection of Alzheimer's disease
Prof. Frank Jessen, Head of the research group Clinical…
DZNE Local principal investigator: Dr. Jennifer Faber Local contact: +49 228 43302-783
DZNE Otto-von-Guericke-Universität Magdeburg - Universitätsklinik für Neurologie Local…
DZNE Local principal investigator: Dr. Jennifer Faber Local contact: +49 228 43302-783
DZNE Friedrich-Baur-Institut an der Neurologischen Klinik Local principal investigator: …
DZNE Local contact: PD. Dr. Jennifer Faber +49 228 43302-783
Universitätsklinikum Tübingen - Zentrum für Neurologie, Abteilung Neurodegenerative Erkrankungen Local contact: Prof. Dr.…
Alamar Biosciences and DZNE partner for Landmark Proteomic Profiling study in the Rhineland Study Cohort
Fremont, CA – July 29, 2025 – Alamar Biosciences, a company powering precision…
European Medicines Agency recommends approval of Alzheimer's drug Donanemab
The European Medicines Agency (EMA) has recommended the approval of the Alzheimer's drug Donanemab (trade name:…
Plan:D - Dementia-friendly architecture, urban environments and places designed for people living with dementia
Background and research question
The German Centre for Neurodegenerative Diseases…
INCLUDE
The research project INCLUDE, funded by Deutsche Demenzhilfe – DZNE Stiftung für Forschung und Innovation, focuses on the perspective of people with dementia: together with DZNE Witten,…
Award for research on childhood hereditary autism: Tobias Böckers honored for findings on Phelan-McDermid Syndrome
The US non-profit organization CureSHANK recently honored Prof. Tobias…
